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PERSPECTIVES ON DRUGS 
Wastewater analysis and drugs: 
a European multi-city study
Wastewater analysis is a rapidly developing scientific 
discipline with the potential for monitoring real-time data on 
geographical and temporal trends in illicit drug use. Originally 
used in the 1990s to monitor the environmental impact of 
liquid household waste, the method has since been used to 
estimate illicit drug consumption in different cities (Daughton, 
2001; Zuccato et al., 2008; van Nuijs et al., 2011). It involves 
sampling a source of wastewater, such as a sewage influent 
to a wastewater treatment plant. This allows scientists to 
estimate the quantity of drugs consumed by a community 
by measuring the levels of illicit drugs and their metabolites 
excreted in urine (Zuccato et al., 2008).
I  Wastewater testing in European cities
In 2010 a Europe-wide network (Sewage analysis CORe 
group — Europe (SCORE)) was established with the aim 
of standardising the approaches used for wastewater 
analysis and coordinating international studies through the 
establishment of a common protocol of action (1). The first 
activity of the SCORE group was a Europe-wide investigation, 
performed in 2011 in 19 European cities, which allowed the 
first ever wastewater study of regional differences in illicit drug 
use in Europe (Thomas et al., 2012). That study also included 
the first intercalibration exercise for the evaluation of the 
quality of the analytical data and allowed a comprehensive 
characterisation of the major uncertainties of the approach 
(Castiglioni et al., 2014). Following the success of this initial 
study, comparable studies were undertaken over the following 
four years, covering 53 cities and 20 countries in Europe in 
2016. A standard protocol and a common quality control 
The findings of the largest European 
project to date in the emerging science 
of wastewater analysis are taken up in 
this ‘Perspective on drugs’. The project in 
question analysed wastewater in over 60 
European cities and towns (hereinafter 
referred to as ‘cities’) to explore the drug-
taking habits of those who live in them. 
The results provide a valuable snapshot of 
the drug flow through the cities involved, 
revealing marked geographical variations.
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(1 ) The protocol can be found on the EMCDDA website: www.emcdda.europa.eu/
wastewater-analysis 
.
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exercise were used in all locations, which made it possible to 
directly compare illicit drug loads in Europe over a one-week 
period during six consecutive years. For the 2016 wastewater 
monitoring campaign, raw 24-hour composite samples were 
collected during a single week in March. These samples 
were analysed for the urinary biomarkers (i.e. measurable 
characteristics) of the parent drug (i.e. primary substance) for 
amphetamine, methamphetamine and MDMA. In addition, the 
samples were analysed for the main urinary metabolites (i.e. 
substances produced when the body breaks drugs down) of 
cocaine and cannabis, which are benzoylecgonine (BE) and 
THC-COOH (11-nor-9-carboxy-delta9-tetrahydrocannabinol).
This report is focused on illicit stimulants. No results for 
cannabis are reported, as the identification of THC-COOH 
loads in wastewater poses some sampling and analytical 
challenges.
I  Patterns of illicit drug use: geographical and temporal variation 
2016 key findings 
The project revealed a picture of distinct geographical and 
temporal patterns of drug use across European cities (see 
Interactive: explore the data from the study).
The BE loads observed in wastewater indicate that cocaine 
use is highest in western and southern European cities, in 
particular in cities in Belgium, Spain and the United Kingdom. 
Wastewater analysis indicates that cocaine use is very low to 
negligible in the majority of eastern European cities.
The loads of amphetamine detected in wastewater varied 
considerably across study locations, with the highest levels 
reported in cities in the north of Europe. Amphetamine was 
found at much lower levels in cities in the south of Europe.
In contrast, methamphetamine use, generally low and 
historically concentrated in the Czech Republic and Slovakia, 
now appears to be present also in the east of Germany and 
northern Europe, particularly in cities in Finland. The observed 
methamphetamine loads in the other locations were very low 
to negligible. 
The highest mass loads of MDMA were found in the 
wastewater in cities in Belgium, the Netherlands and Norway.
Ten countries participating in the 2016 monitoring campaign 
included two or more study locations (Belgium, Cyprus, 
Germany, Spain, Finland, France, the Netherlands, Portugal, 
Slovakia and UK). The study highlighted differences between 
these cities within the same country, which may be explained 
in part by the different social and demographic characteristics 
of the cities (universities, nightlife areas and age distribution 
of the population). In the large majority of countries with 
multiple study locations, cocaine and MDMA loads were 
higher in large cities compared to smaller locations. No 
such differences could be detected for amphetamine and 
methamphetamine.
In addition to geographical patterns, wastewater analysis can 
detect fluctuations in weekly patterns of illicit drug use. More 
than three-quarters of cities show higher loads of BE and 
MDMA in wastewater during the weekend (Friday to Monday) 
than during weekdays. In contrast, amphetamine use was 
found to be distributed more evenly over the whole week.
Five-year trend data
A relatively stable picture of cocaine use can be observed 
over five years. The general patterns detected were similar 
in the six consecutive monitoring campaigns, with the 
highest and lowest BE loads found in the same cities and 
regions. Most cities show either a decreasing or a stable 
trend between 2011 and 2015, but there are signs that this 
pattern may have changed with 22 out of 33 cities that have 
data for 2015 and 2016 reporting an increase. In a few cases, 
including London and Zagreb, a longer-term increase in BE 
loads found in wastewater over the 2011–16 period has been 
notified. 
Over the six years of monitoring the highest MDMA loads 
were consistently found in the wastewater of cities in Belgium 
and the Netherlands. Looking at longer term trends, in most 
cities with at least five data points wastewater MDMA loads 
were higher in 2016 than in 2011, with sharp increases 
observed in some cities, including Antwerp and Oslo. 
Overall, the data related to amphetamine and 
methamphetamine from the six monitoring campaigns 
showed no major changes in the general patterns of use 
observed.
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I  Comparison with findings from other monitoring tools
Because different types of information are provided by 
wastewater analysis (collective consumption of substances 
within a community) and by established monitoring tools, 
such as population surveys (prevalence in the last month or 
year), a direct comparison of the data is difficult. However, the 
patterns and trends being detected by wastewater analysis 
are largely, but not completely, in line with the analyses 
coming from other monitoring tools.
For example, both seizure and wastewater data present 
a picture of a geographically divergent stimulant market 
in Europe, where cocaine is more prevalent in the south 
and west, while amphetamines are more common in 
central and northern countries (EMCDDA, 2017). While 
the general pattern detected in wastewater is in line with 
established monitoring tools, there are some exceptions: 
the amphetamine loads in wastewater in Paris have been 
below the level of quantification over the consecutive annual 
monitoring campaigns, contrary to indications from other 
monitoring tools.
Data from established indicators show that 
methamphetamine use has historically been restricted to the 
Czech Republic, and more recently also Slovakia, although 
recent years have seen increased use in other countries 
(EMCDDA, 2016a). These findings have been confirmed by 
recent wastewater-based epidemiology, with the highest 
methamphetamine loads found in Czech, Slovak, German 
and Finnish cities.
Established indicators show that, until recently, MDMA 
prevalence was declining in many countries from peak levels 
in the early to mid 2000s. Data from wastewater and from 
established indicators show that this appears to be changing, 
with the large majority of cities reporting higher wastewater 
MDMA loads in 2016 than in 2011.
Similarly, studies based on self-reported drug use and those 
using wastewater data both point towards the same weekly 
variations in use, with stimulants such as amphetamine and 
cocaine being primarily used at weekend music events and in 
celebratory contexts (Tossmann et al., 2001).
A limited but steadily increasing number of studies have 
been published comparing drug use estimates obtained 
through wastewater analysis and estimates provided by 
epidemiological surveys (EMCDDA, 2016b; van Wel et al., 
2015). While in 2012 only one reported study tried to evaluate 
sewage analysis alongside traditional epidemiological 
techniques (Reid et al., 2012), this number has now 
increased to around 20 published research articles that are 
focused on comparing information provided by wastewater 
analysis and information provided by other indicators.    
A first study, performed in Oslo, Norway, and published in 
2012, compared the results from three different datasets (a 
general population survey, a roadside survey and wastewater 
analysis) (Reid et al., 2012). 
Other, more recent studies compare and correlate 
wastewater-based consumption estimates of illicit drugs 
with other data sources, including self-reported data (Been 
et al., 2015; Castiglioni et al., 2016; van Wel et al., 2016a), 
consumption offences (Been et al., 2016a), illicit drug 
seizures (Baz-Lomba et al., 2016; Kankaanpää et al., 2014, 
2016), syringe distribution estimates (Been et al., 2015) 
toxicological data (Kankaanpää et al., 2014, 2016) and the 
number of drug users in treatment (Krizman et al., 2016).  
The majority of comparative studies have been carried out 
within Europe, including in Belgium (van Wel et al., 2016a), 
Croatia (Krizman et al., 2016), Germany (Been et al., 2016a), 
Finland (Kankaanpää et al., 2014, 2016), Italy (Castiglioni et 
al., 2016), Switzerland (Been et al., 2015; Been et al., 2016b) 
I  Terms and definitions 
Back-calculation is the process whereby researchers 
calculate/estimate the consumption of illicit drugs in 
the population based on the amounts of the target drug 
residue entering the wastewater treatment plant.
Liquid chromatography–tandem mass spectrometry 
(LC-MS/MS) is the analytical method most commonly 
used to quantify drug residues in wastewater. LC-MS/MS 
is an analytical chemistry technique that combines the 
separation techniques of liquid chromatography with the 
analysis capabilities of mass spectrometry. Considering 
the complexity and the low concentrations expected 
in wastewater, LC-MS/MS is one of the most powerful 
techniques for this analysis, because of its sensitivity and 
selectivity.
Metabolite  Traces of drugs consumed will end up in 
the sewer network either unchanged or as a mixture of 
metabolites. Metabolites, the end products of metabolism, 
are the substances produced when the body breaks drugs 
down. 
Residue  Wastewater analysis is based on the fact that 
we excrete traces in our urine of almost everything we 
consume, including illicit drugs. The target drug residue 
is what remains in the wastewater after excretion and is 
used to quantify the consumption of illicit drugs in the 
population.
Urinary biomarkers  Analytical chemists look for urinary 
biomarkers (measurable characteristics to calculate 
population drug use) in wastewater samples, which can be 
the parent drug (i.e. the primary substance) or its urinary 
metabolites.
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and across European countries (Baz-Lomba et al., 2016). 
Outside Europe, in recent years studies have been published 
comparing wastewater-based estimates with other data 
sources in China (Du et al., 2015) and Australia (Tscharke et 
al., 2015). 
These examples confirm the promising future of wastewater-
based epidemiology as a complementary approach to 
obtain a more accurate and balanced picture of substance 
use within different communities. Wastewater analysis can 
predict results from population surveys and can be used as 
a ‘first alert’ tool in the identification of new trends in drug 
consumption.
I  Limitations of this method
Wastewater analysis offers an interesting complementary 
data source for monitoring the quantities of illicit drugs used 
at the population level, but it cannot provide information 
on prevalence and frequency of use, main classes of users 
and purity of the drugs. Additional challenges arise from 
uncertainties associated with the behaviour of the selected 
biomarkers in the sewer, different back-calculation methods 
and different approaches to estimate the size of the 
population being tested (Castiglioni et al., 2013, 2016; Lai 
et al., 2014; EMCDDA, 2016b). The caveats in selecting the 
analytical targets for heroin, for example, make monitoring 
this drug in wastewater more complicated compared to other 
substances (Been et al., 2015). Also, the purity of street 
products fluctuates unpredictably over time and in different 
locations. Furthermore, translating the total consumed 
amounts into the corresponding number of average doses is 
complicated, as drugs can be taken by different routes and in 
amounts that vary widely, and purity levels fluctuate (Zuccato 
et al., 2008).
The necessary sampling intervals for wastewater samples 
to reduce random biases and produce reliable annual 
consumption estimates is an issue that will be further 
explored in the 2017 SCORE annual monitoring campaign 
(http://score-cost.eu/monitoring2017/).
I New developments and the future
Wastewater-based epidemiology has established itself as 
an important tool for monitoring illicit drug use and future 
directions for wastewater research have been explored 
(EMCDDA, 2016b).
First, wastewater analysis has been proposed as a tool to 
address some of the challenges related to the dynamic new 
psychoactive substances (NPS) market. This includes the 
large number of individual NPS, the relatively low prevalence 
of use and the fact that many of the users are actually 
unaware of exactly which substances they are using. A new 
technique has been established to identify NPS that involves 
the collection and analysis of pooled urine from stand-alone 
portable urinals from nightclubs, city centres and music 
festivals, thereby providing timely data on exactly which NPS 
are currently in use at a particular location (Archer et al., 
2013a, 2013b, 2015; Reid et al., 2014; Kinyua, et al., 2016).
Second, in addition to estimating illicit drug use, wastewater-
based epidemiology has been successfully applied in recent 
years to providing detailed information on the use and misuse 
of alcohol (Boogaerts et al., 2016; Rodríguez-Álvarez et al., 
2015), tobacco (Senta et al., 2015; van Wel et al., 2016b) 
and medicines in a specific population (Been et al., 2015; 
Salvatore et al., 2016; Baz-Lomba, 2016). Furthermore, 
wastewater analysis can potentially provide information on 
health and illness indicators within a community (Yang et al., 
2015; Kasprzyk-Hordern et al., 2014).
Third, the potential for wastewater-based epidemiology to be 
used as an outcome measurement tool, in particular in the 
evaluation of the effectiveness of interventions that target 
drug supply (e.g. law enforcement) or drug demand (e.g. 
public health campaigns) has not yet been fully explored. 
Close collaboration between the different stakeholders 
involved, including epidemiologists, wastewater experts and 
legal authorities, is highly recommended in order to start 
examining these potential wastewater-based epidemiology 
applications (EMCDDA, 2016b).
Fourth, by back-calculating the daily sewer loads of target 
residues, wastewater analysis can provide total consumption 
estimates, and specific efforts are now being directed 
towards finding the best procedures for estimating annual 
averages. In 2016 the EMCDDA presented for the first time 
illicit drug retail market size estimates in terms of quantity 
and value for the main substances used (EMCDDA and 
Interactive: explore the data from the study, available on the EMCDDA website: 
emcdda.europa.eu/topics/pods/waste-water-analysis
I  Interactive element
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Europol, 2016c). It is envisaged that findings from wastewater 
analysis can help to further develop work in this area.
Finally, new methods such as enantiomeric profiling have 
been developed to determine if mass loads of drugs in 
wastewater originated from consumption or from the disposal 
of unused drugs or production waste. It is now important to 
assess the possible utility of wastewater analysis to report on 
drug supply dynamics, including synthetic drug production.
Wastewater analysis has demonstrated its potential as 
a useful complement to established monitoring tools in 
the drugs area. It has some clear advantages over other 
approaches as it is not subject to response and non-
response bias and can better identify the true spectrum of 
drugs being consumed, as users are often unaware of the 
actual mix of substances they take. This tool also has the 
potential to provide timely information in short timeframes 
on geographical and temporal trends. In order to check the 
quality and accuracy of data, further comparisons between 
wastewater analysis and data obtained through other 
indicators are needed. 
As a method, wastewater analysis has moved from being 
an experimental technique to being a new method in the 
epidemiological toolkit. Its rapid ability to detect new trends 
can help target public health programmes and policy 
initiatives at specific groups of people and the different drugs 
they are using.
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 Wastewater analysis approach
In order to estimate levels of drug use from wastewater, 
researchers attempt first to identify and quantify drug 
residues, and then to back-calculate the amount of the 
illicit drugs used by the population served by the sewage 
treatment plants (Castiglioni et al., 2014). This approach 
involves several steps (see figure). Initially, composite 
samples of untreated wastewater are collected from the 
sewers in a defined geographical area. The samples are 
then analysed to identify concentrations of the target drug 
residues. Following this, the drug use is estimated through 
back-calculation by multiplying the concentration of each 
target drug residue (ng/L) with the corresponding flow of 
sewage (L/day). A correction factor for each drug is taken 
into account as part of the calculation. In a last step, the 
result is divided by the population served by the wastewater 
treatment plant, which shows the amount of a substance 
consumed per day per 1 000 inhabitants. Population 
estimates can be calculated using different biological 
parameters, census data, number of house connections, or 
the design capacity, but the overall variability of different 
estimates is generally very high. 
Although primarily used to study trends in illicit drug 
consumption in the general population, wastewater analysis 
has also been applied to small communities, including 
workplaces, schools, music festivals, prisons and specific 
neighbourhoods (Hall et al., 2012).  
 
Using this method in small communities can involve ethical 
risks (Prichard et al., 2014), such as possible identification 
of a particular group within the community. 
 
In 2016 the SCORE group published ethical guidelines for 
wastewater-based epidemiology and related fields (Prichard 
et al., 2016).  The objective of these guidelines is to outline 
the main potential ethical risks for wastewater research and 
to propose strategies to mitigate those risks. Mitigating risks 
means reducing the likelihood of negative events and/or 
minimising the consequences of negative events.
Understanding the wastewater method, and addressing ethical issues  
Flow rate (m3/day)
Mean dose
Population estimates
Human metabolism
correction factors
2. Sample analysis to obtain the 
concentrations of the target residues
1. Sample collection
(composite 24-h samples)
6. Amount of substance as doses/day/1 000 inhabitants
5. Normalisation of the amount of substance
to a dened population (g or mg/day/1 000 inhabitants)
4. Amount of a substance consumed by the 
population served by the treatment plant 
3. Amount of target residues entering
the treatment plant (g/day)
Source: (Castiglioni et al., 2013a)
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